Petr Jarolı́m - Concepedia

Author

Petr Jarolı́m

Also Known As

Finn, Peter, JAROLIM Petr, Jarolim Petr, Jarolim, P., Jarolim, Petr, P Jarolim, P Jarolím, P. Jarolim, PETR JAROLIM, Petr Jarolim

358

Publications

13.4K

Citations

H-Index

142

Concepts

All Affiliations

Brigham and Women's Hospital Harvard University Thrombolysis in Myocardial Infarction Study Group Massachusetts General Hospital The University of Texas Southwestern Medical Center

About

Petr Jarolı́m is an author at Brigham and Women's Hospital specializing in medicine, cardiovascular disease, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	33	53	3.9K
2	Public Health	14	17	1.4K
3	Health Sciences	4	4	201
4	Natural Sciences	2	2	174
5	Social Sciences	1	1	21

Petr Jarolı́m

140

Publications

10.3K

Citations

H-Index

Page 1

	Year	Citations
Heart Failure, Saxagliptin, and Diabetes Mellitus: Observations from the SAVOR-TIMI 53 Randomized Trial Benjamin M. Scirica, Eugene Braunwald, Itamar Raz, Circulation	2014	718
Myocardial Fibrosis as an Early Manifestation of Hypertrophic Cardiomyopathy Carolyn Y. Ho, Begoña López, Otávio R. Coelho‐Filho, New England Journal of Medicine	2010	692
Timing and Magnitude of Increases in Levothyroxine Requirements during Pregnancy in Women with Hypothyroidism Erik K. Alexander, Ellen Marqusee, Jennifer L. Lawrence, New England Journal of Medicine	2004	637
Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial Christian T. Ruff, Robert P. Giugliano, Eugene Braunwald, The Lancet Anti-factor Xa ActivityEdoxaban DoseClinical EpidemiologyClinical TrialsPharmacology	2015	389
How to Interpret Elevated Cardiac Troponin Levels Vinay S. Mahajan, Petr Jarolı́m Circulation CardiomyopathyCardiovascular DiseaseMyocardial InfarctionPhysiologyCardiology	2011	315
Distinct Subgroups in Hypertrophic Cardiomyopathy in the NHLBI HCM Registry Stefan Neubauer, Paul Kolm, Carolyn Y. Ho, Journal of the American College of Cardiology CardiomyopathyCardiovascular DiseasePhysiologyGenetic EpidemiologyDistinct Subgroups	2019	295
Impairment of the Programmed Cell Death-1 Pathway Increases Atherosclerotic Lesion Development and Inflammation De-xiu Bu, Margarite L. Tarrio, Elena Maganto-García, Arteriosclerosis Thrombosis and Vascular Biology	2011	252
Effects of Canagliflozin on Cardiovascular Biomarkers in Older Adults With Type 2 Diabetes James L. Januzzi, Javed Butler, Petr Jarolı́m, Journal of the American College of Cardiology	2017	209
Earlier Detection of Myocardial Injury in a Preliminary Evaluation Using a New Troponin I Assay With Improved Sensitivity Stacy E.F. Melanson, David A. Morrow, Petr Jarolı́m American Journal of Clinical Pathology Heart FailureNew TroponinDiagnosisAcute Myocardial InfarctionClinical Diagnosis	2007	208
Elevated Plasma Levels of the Atherogenic Mediator Soluble CD40 Ligand in Diabetic Patients Nerea Varo, David Vicent, Peter Libby, Circulation	2003	199

Page 1